UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 272

Sortiert nach

Growth and nutrition in pediatric neuromuscular disorders

Clinical nutrition (Edinburgh, Scotland), 2021-06, Vol.40 (6), p.4341-4348

2021

Link zum Volltext

Verfügbarkeit prüfen

Proteomic analysis of first trimester maternal serum to identify candidate biomarkers potentially predictive of spontaneous preterm birth

Journal of proteomics, 2018-04, Vol.178, p.31-42

2018

Link zum Volltext

Verfügbarkeit prüfen

Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme

Developmental medicine and child neurology, 2022-05, Vol.64 (5), p.625-632

2022

Link zum Volltext

Verfügbarkeit prüfen

First Trimester Protein Biomarkers for Risk of Spontaneous Preterm Birth: Identifying a Critical Need for More Rigorous Approaches to Biomarker Identification and Validation

Fetal diagnosis and therapy, 2020-06, Vol.47 (6), p.497-506

2020

Link zum Volltext

Verfügbarkeit prüfen

Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study

The lancet child & adolescent health, 2023-03, Vol.7 (3), p.159-170

2023

Link zum Volltext

Verfügbarkeit prüfen

Axonal excitability changes in children with spinal muscular atrophy treated with nusinersen

The Journal of physiology, 2022-01, Vol.600 (1), p.95-109

2022

Link zum Volltext

Verfügbarkeit prüfen

Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy

Annals of clinical and translational neurology, 2022-03, Vol.9 (3), p.339-350

2022

Link zum Volltext

Verfügbarkeit prüfen

Characterizing Common Phenotypes Across the Childhood Dementia Disorders: A Cross-sectional Study From Two Australian Centers

Pediatric neurology, 2023-12, Vol.149, p.75-83

2023

Link zum Volltext

Verfügbarkeit prüfen

“We needed this”: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy

EClinicalMedicine, 2021-03, Vol.33, p.100742-100742, Article 100742

2021

Link zum Volltext

Verfügbarkeit prüfen

Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective

Expert review of neurotherapeutics, 2023-07, Vol.23 (7), p.571-586

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study

Pharmaceutics, 2023-01, Vol.15 (1), p.170

2023

Link zum Volltext

Verfügbarkeit prüfen

Differential Placental Gene Expression in Term Pregnancies Affected by Fetal Growth Restriction and Macrosomia

Fetal diagnosis and therapy, 2014-01, Vol.36 (2), p.173-180

2014

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Duchenne muscular dystrophy in the modern era; an Australian study

European journal of human genetics : EJHG, 2022-12, Vol.30 (12), p.1398-1404

2022

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy

Frontiers in neurology, 2019-08, Vol.10, p.898-898

2019

Link zum Volltext

Verfügbarkeit prüfen

Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review

Orphanet journal of rare diseases, 2020-03, Vol.15 (1), p.70-70, Article 70

2020

Link zum Volltext

Verfügbarkeit prüfen

"Getting ready for the adult world": how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being

Orphanet journal of rare diseases, 2019-04, Vol.14 (1), p.74-74, Article 74

2019

Link zum Volltext

Verfügbarkeit prüfen

Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy

Molecular therapy, 2023-07, Vol.31 (7), p.1979-1993

2023

Link zum Volltext

Verfügbarkeit prüfen

A Routine 'Top-Down' Approach to Analysis of the Human Serum Proteome

Proteomes, 2017-06, Vol.5 (2), p.13

2017

Link zum Volltext

Verfügbarkeit prüfen

WE-149. Axonal excitability changes in children with spinal muscular atrophy treated with nusinersen

Clinical neurophysiology, 2022-09, Vol.141, p.S73-S74

2022

Link zum Volltext

Verfügbarkeit prüfen

Lessons from School Psychology: Practical Strategies and Evidence-Based Practice for Professionals and Parents

1, 2019

Link zum Volltext

Verfügbarkeit prüfen

Ethnopharmacology of medicinal plants of carrasco, northeastern Brazil

Journal of ethnopharmacology, 2014-11, Vol.157, p.99-104

2014

Link zum Volltext

Verfügbarkeit prüfen

The Carrier Frequency of Two SMN1 Genes in Parents of Symptomatic Children with SMA and the Significance of SMN1 Exon 8 in Carriers

Genes, 2023-07, Vol.14 (7), p.1403

2023

Link zum Volltext

Verfügbarkeit prüfen

Personalized medicine for children with spinal muscular atrophy: Toward the holy grail

Muscle & nerve, 2020-10, Vol.62 (4), p.425-426

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world respiratory and bulbar comorbidities of SMA type 1 children treated with nusinersen: 2-Year single centre Australian experience

Paediatric respiratory reviews, 2021-09, Vol.39, p.54-60

2021

Link zum Volltext

Verfügbarkeit prüfen

First trimester prediction and prevention of adverse pregnancy outcomes related to poor placentation

Current opinion in obstetrics & gynecology, 2017-12, Vol.29 (6), p.367-374

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 272

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(258)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Growth and nutrition in pediatric neuromuscular disorders

Proteomic analysis of first trimester maternal serum to identify candidate biomarkers potentially predictive of spontaneous preterm birth

Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme

First Trimester Protein Biomarkers for Risk of Spontaneous Preterm Birth: Identifying a Critical Need for More Rigorous Approaches to Biomarker Identification and Validation

Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study

Axonal excitability changes in children with spinal muscular atrophy treated with nusinersen

Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy

Characterizing Common Phenotypes Across the Childhood Dementia Disorders: A Cross-sectional Study From Two Australian Centers

“We needed this”: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy

Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective

Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study

Differential Placental Gene Expression in Term Pregnancies Affected by Fetal Growth Restriction and Macrosomia

Incidence of Duchenne muscular dystrophy in the modern era; an Australian study

Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy

Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review

"Getting ready for the adult world": how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being

Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy

A Routine 'Top-Down' Approach to Analysis of the Human Serum Proteome

WE-149. Axonal excitability changes in children with spinal muscular atrophy treated with nusinersen

Lessons from School Psychology: Practical Strategies and Evidence-Based Practice for Professionals and Parents

Ethnopharmacology of medicinal plants of carrasco, northeastern Brazil

The Carrier Frequency of Two SMN1 Genes in Parents of Symptomatic Children with SMA and the Significance of SMN1 Exon 8 in Carriers

Personalized medicine for children with spinal muscular atrophy: Toward the holy grail

Real-world respiratory and bulbar comorbidities of SMA type 1 children treated with nusinersen: 2-Year single centre Australian experience

First trimester prediction and prevention of adverse pregnancy outcomes related to poor placentation

Suchergebnisse filtern